Steward Partners Investment Advisory’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.04K | Buy |
10
+6
| +150% | +$626 | ﹤0.01% | 3850 |
|
|
2025
Q1 | $467 | Hold |
4
| – | – | ﹤0.01% | 3866 |
|
|
2024
Q4 | $338 | Buy |
+4
| New | +$338 | ﹤0.01% | 3878 |
|
|
2022
Q4 | – | Sell |
-214
| Closed | -$10K | – | 3365 |
|
|
2022
Q3 | $10K | Sell |
214
-4,286
| -95% | -$200K | ﹤0.01% | 2518 |
|
|
2022
Q2 | $172K | Hold |
4,500
| – | – | ﹤0.01% | 1268 |
|
|
2022
Q1 | $186K | Hold |
4,500
| – | – | ﹤0.01% | 1328 |
|
|
2021
Q4 | $170K | Buy |
4,500
+700
| +18% | +$26.4K | ﹤0.01% | 1379 |
|
|
2021
Q3 | $125K | Buy |
3,800
+3,700
| +3,700% | +$122K | ﹤0.01% | 1458 |
|
|
2021
Q2 | $7K | Sell |
100
-400
| -80% | -$28K | ﹤0.01% | 6357 |
|
|
2021
Q1 | $28.3K | Buy |
+500
| New | +$28.3K | ﹤0.01% | 2295 |
|